factually
Index/Topics/Neuroprotective agents

Neuroprotective agents

The development and testing of neuroprotective agents as potential treatments for Alzheimer disease and other neurodegenerative disorders.

Fact-Checks

2 results
Jan 31, 2026
Most Viewed

What clinical trial evidence supports LM11A‑31 or other neuroprotective drug candidates for Alzheimer’s?

, a small‑molecule modulator of the p75 neurotrophin receptor (p75NTR), completed a randomized, double‑blind, placebo‑controlled phase 2a trial in 242 people with mild–moderate and met its prespecifie...

Feb 2, 2026

What randomized clinical trials exist testing honey or honey-derived compounds for cognitive impairment in humans?

A small but heterogeneous set of randomized human trials has examined honey or honey-containing formulations for cognitive outcomes, but no large, independently replicated randomized controlled trials...